NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

This Week on NeurologyLive — April 5, 2021

This Week on NeurologyLive — April 5, 2021

NeurologyLive® Staff
April 5th 2021

Here's what is coming soon to NeurologyLive.

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

NeurologyLive® Staff
April 3rd 2021

Neurology News Network for the week ending April 3, 2021.

NeurologyLive Friday 5 — April 2, 2021

NeurologyLive Friday 5 — April 2, 2021

NeurologyLive® Staff
April 2nd 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 2, 2021.

This Week on NeurologyLive — March 29, 2021

This Week on NeurologyLive — March 29, 2021

NeurologyLive® Staff
March 29th 2021

Here's what is coming soon to NeurologyLive.

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

NeurologyLive® Staff
March 27th 2021

Neurology News Network for the week ending March 27, 2021.

NeurologyLive Friday 5 — March 26, 2021

NeurologyLive Friday 5 — March 26, 2021

NeurologyLive® Staff
March 26th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 26, 2021.

Outcomes and Risk Factors Associated with COVID-19 and Multiple Sclerosis Published

Outcomes and Risk Factors Associated with COVID-19 and Multiple Sclerosis Published

NeurologyLive® Staff
March 24th 2021

Increased disability was independently associated with worse clinical severity including death from COVID-19.

This Week on NeurologyLive — March 22, 2021

This Week on NeurologyLive — March 22, 2021

NeurologyLive® Staff
March 22nd 2021

Here's what is coming soon to NeurologyLive.

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

NeurologyLive® Staff
March 20th 2021

Neurology News Network for the week ending March 20, 2021.

NeurologyLive Friday 5 — March 19, 2021

NeurologyLive Friday 5 — March 19, 2021

NeurologyLive® Staff
March 19th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 19, 2021.

This Week on NeurologyLive — March 15, 2021

This Week on NeurologyLive — March 15, 2021

NeurologyLive® Staff
March 15th 2021

Here's what is coming soon to NeurologyLive.

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

NeurologyLive® Staff
March 13th 2021

Neurology News Network for the week ending March 13, 2021.

NeurologyLive Friday 5 — March 12, 2021

NeurologyLive Friday 5 — March 12, 2021

NeurologyLive® Staff
March 12th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 12, 2021.

This Week on NeurologyLive — March 8, 2021

This Week on NeurologyLive — March 8, 2021

NeurologyLive® Staff
March 8th 2021

Here's what is coming soon to NeurologyLive.

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

NeurologyLive® Staff
March 6th 2021

Neurology News Network for the week ending March 6, 2021.

NeurologyLive Friday 5 — March 5, 2021

NeurologyLive Friday 5 — March 5, 2021

NeurologyLive® Staff
March 5th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 5, 2021.

This Week on NeurologyLive — March 1, 2021

This Week on NeurologyLive — March 1, 2021

NeurologyLive® Staff
March 1st 2021

Here's what is coming soon to NeurologyLive.

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

NeurologyLive® Staff
February 27th 2021

Neurology News Network for the week ending February 27, 2021.

NeurologyLive Friday 5 — February 26, 2021

NeurologyLive Friday 5 — February 26, 2021

NeurologyLive® Staff
February 26th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 26, 2021.

This Week on NeurologyLive — February 22, 2021

This Week on NeurologyLive — February 22, 2021

NeurologyLive® Staff
February 22nd 2021

Here's what is coming soon to NeurologyLive.

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

NeurologyLive® Staff
February 20th 2021

Neurology News Network for the week ending February 20, 2021.

NeurologyLive Friday 5 — February 19, 2021

NeurologyLive Friday 5 — February 19, 2021

NeurologyLive® Staff
February 19th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 19, 2021.

This Week on NeurologyLive — February 15, 2021

This Week on NeurologyLive — February 15, 2021

NeurologyLive® Staff
February 15th 2021

Here's what is coming soon to NeurologyLive.

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

NeurologyLive® Staff
February 13th 2021

Neurology News Network for the week ending February 13, 2021.

NeurologyLive Friday 5 — February 12, 2021

NeurologyLive Friday 5 — February 12, 2021

NeurologyLive® Staff
February 12th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 12, 2021.

NeurologyLive Wants Your Feedback: Q1 2021 Audience Survey

NeurologyLive Wants Your Feedback: Q1 2021 Audience Survey

NeurologyLive® Staff
February 11th 2021

We kindly ask you to share 5 minutes of your time with us in order to help us better craft our content to meet your needs.

This Week on NeurologyLive — February 8, 2021

This Week on NeurologyLive — February 8, 2021

NeurologyLive® Staff
February 8th 2021

Here's what is coming soon to NeurologyLive.

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

NeurologyLive® Staff
February 6th 2021

Neurology News Network for the week ending February 6, 2021.

NeurologyLive Friday 5 — February 5, 2021

NeurologyLive Friday 5 — February 5, 2021

NeurologyLive® Staff
February 5th 2021

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 5, 2021.

CMSC Announces New Fall Dates & Location for its 2021 Annual Meeting

CMSC Announces New Fall Dates & Location for its 2021 Annual Meeting

NeurologyLive® Staff
February 5th 2021

The annual meeting will now take place October 25–28, 2021 at the Rosen Shingle Creek in Orlando, Florida.

<1
...
222324252627282930
...
36>

Latest Updated Articles

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
Published: February 4th 2025 | Updated: February 6th 2025
FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
Published: January 30th 2025 | Updated: February 4th 2025
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
© 2025 MJH Life Sciences

All rights reserved.